Joslin Diabetes Center is the world’s largest diabetes research center, diabetes clinic, and provider of diabetes education
The Latest Bing News on:
Joslin Diabetes Center Research
- CSOFT CEO Shunee Yee Appointed Co-Chair of A Taste of Ginger for Joslin Diabetes Centeron April 29, 2021 at 5:00 am
CSOFT Health Sciences, leaders in medical translation and market access consulting, announced today that CSOFT Founder and CEO Ms. Shunee ...
- RenalytixAI and Joslin Diabetes Center Build on Proprietary Kidney Biomarker Portfolio for KidneyIntelX Platformon April 22, 2021 at 6:55 am
Genetics and Epidemiology at Joslin Diabetes Center and Professor of Medicine, Harvard Medical School, along with his research team at Joslin, as well as other collaborators. Dr. Krolewski and his ...
- RenalytixAI and Joslin Diabetes Center Build on Proprietary Kidney Biomarker Portfolio for KidneyIntelX Platformon April 14, 2021 at 4:11 am
Genetics and Epidemiology at Joslin Diabetes Center and Professor of Medicine, Harvard Medical School, along with his research team at Joslin, as well as other collaborators. Dr. Krolewski and his ...
- RenalytixAI and Joslin Diabetes Center Build on Proprietary Kidney Biomarker Portfolio for KidneyIntelX Platformon April 14, 2021 at 4:00 am
NEW YORK, April 14, 2021 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) announced today that it has entered into an exclusive option agreement with Joslin Diabetes Center for patent ...
- Renalytix AI enters option agreement with Joslin Diabetes Centeron April 14, 2021 at 2:02 am
No news or research item is a personal recommendation ... Renalytix AI has entered into an exclusive option agreement with Joslin Diabetes Center for patent filings on additional novel biomarkers ...
The Latest Google Headlines on:
Joslin Diabetes Center Research
The Latest Bing News on:
Joslin Diabetes Center Discovery
- Dementia Risk Rises as Years Lived With Type 2 Diabetes Increaseson April 29, 2021 at 7:50 am
At age 70, the study found, people who'd recently been diagnosed with type 2 diabetes had no greater risk of dementia than those without diabetes. The picture was different for pe ...
- CSOFT CEO Shunee Yee Appointed Co-Chair of A Taste of Ginger for Joslin Diabetes Centeron April 29, 2021 at 5:00 am
CSOFT Health Sciences, leaders in medical translation and market access consulting, announced today that CSOFT Founder and CEO Ms. Shunee ...
- Type 1 Diabetes Medalists: How Celebrating Decades of Success Is Changing Treatmentson April 20, 2021 at 10:00 pm
Did you know you can get a medal for decades of survival with type 1 diabetes? Here’s how that program is changing care.
- RenalytixAI and Joslin Diabetes Center Build on Proprietary Kidney Biomarker Portfolio for KidneyIntelX Platformon April 14, 2021 at 4:32 am
NEW YORK, April 14, 2021 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ:RNLX) announced today that it has entered into an exclusive option agreement with Joslin Diabetes Center for ...
- RenalytixAI and Joslin Diabetes Center Build on Proprietary Kidney Biomarker Portfolio for KidneyIntelX Platformon April 14, 2021 at 4:11 am
In 2018, RenalytixAI secured an exclusive license from Joslin Diabetes Center to intellectual property relating to sTNFR1 and sTNFR2, both of which have been extensively validated as highly ...
The Latest Google Headlines on:
Joslin Diabetes Center Discovery
